Neurotransmitter
(Redirected from Dopamine system)
Neurotransmitters are endogenous chemicals that play a pivotal role in the transmission of signals across neurons. They act as messengers in the central nervous system, facilitating communication between neurons and ultimately leading to changes in the physical and mental state of the organism.
Function[edit | edit source]
Neurotransmitters carry, amplify and modulate signals between neurons and other cells in the body. They do this by binding to specific receptors on the target neuron's cell membrane, causing a series of biochemical reactions that eventually result in a change in the neuron's electrical potential. This change can either stimulate or inhibit the firing of an action potential, which is the electrical signal that travels down a neuron and leads to the release of neurotransmitters into the next synapse.
Classification[edit | edit source]
Neurotransmitters are broadly classified into two categories: small-molecule neurotransmitters and larger neuropeptides. The small-molecule neurotransmitters, such as glutamate, GABA, dopamine, norepinephrine, serotonin, and acetylcholine, are often responsible for fast synaptic transmission. In contrast, neuropeptides, like endorphins and oxytocin, usually modulate neuronal activity in a slower and longer-lasting manner.
Synthesis and Release[edit | edit source]
Neurotransmitters are synthesized in the neuron from various precursors, often amino acids or other small molecules. The process usually takes place in the cell body or axon of the neuron, facilitated by specific enzymes. Once synthesized, the neurotransmitters are packaged into vesicles and transported to the synapse, ready for release.
The release of neurotransmitters occurs through the process of exocytosis. Upon the arrival of an action potential at the axon terminal, voltage-gated calcium channels open, allowing an influx of calcium ions. This triggers the fusion of the neurotransmitter-filled vesicles with the cell membrane and the subsequent release of the neurotransmitters into the synaptic cleft.
Removal and Degradation[edit | edit source]
After their release, neurotransmitters can be removed from the synaptic cleft in various ways. Some are reabsorbed by the neuron that released them in a process called reuptake. Others are broken down by enzymes in the synapse, while others still diffuse away from the synapse.
Role in Disease and Treatment[edit | edit source]
Abnormalities in neurotransmitter systems are implicated in a range of diseases. For instance, Parkinson's disease is associated with a depletion of dopamine, while Alzheimer's disease involves a deficiency in acetylcholine. Similarly, many psychiatric disorders like depression and schizophrenia are thought to involve imbalances in neurotransmitters.
Treatment strategies for these diseases often involve targeting neurotransmitter systems. For instance, selective serotonin reuptake inhibitors (SSRIs) are used in the treatment of depression, and dopamine agonists are used in the management of Parkinson's disease.
Receptor Interaction[edit | edit source]
Once released, neurotransmitters interact with receptors on the target neuron. There are two major types of receptors: ionotropic and metabotropic receptors. Ionotropic receptors form an ion channel pore that activates quickly upon the binding of a neurotransmitter, resulting in a rapid response. In contrast, metabotropic receptors are linked to signal proteins and lead to slower, longer-lasting effects.
Neurotransmitter Systems[edit | edit source]
Each neurotransmitter can be part of various neurotransmitter systems, each with its specific neurons, receptors, and functions. For instance, the dopaminergic system is involved in reward, motivation, and the regulation of movement, while the serotonergic system is involved in mood regulation, appetite, and sleep.
Impact on Behavior and Cognition[edit | edit source]
Neurotransmitters play a vital role in shaping everyday life and functions. Their impact extends to both cognition – affecting memory, learning, and mood – and behavior, influencing a myriad of actions from voluntary movement to the physiological response to stress and fear.
Research and Future Directions[edit | edit source]
While much is known about neurotransmitters and their function, ongoing research continues to explore this complex and critical aspect of neuroscience. This includes investigating the involvement of neurotransmitters in various pathological conditions, the development of new drugs targeting neurotransmitter systems, and the fundamental understanding of how these intricate systems contribute to the complex functions of the human brain.
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD